Lung cancer LDCT screening and mortality reduction—evidence, pitfalls and future perspectives

M Oudkerk, SY Liu, MA Heuvelmans… - Nature reviews Clinical …, 2021 - nature.com
In the past decade, the introduction of molecularly targeted agents and immune-checkpoint
inhibitors has led to improved survival outcomes for patients with advanced-stage lung …

Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies

L Succony, DM Rassl, AP Barker, FM McCaughan… - Cancer treatment …, 2021 - Elsevier
Adenocarcinoma has become the most prevalent lung cancer sub-type and its frequency is
increasing. The earliest stages in the development of lung adenocarcinomas are visible …

Screening for lung cancer: CHEST guideline and expert panel report

PJ Mazzone, GA Silvestri, S Patel, JP Kanne… - Chest, 2018 - Elsevier
Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States in the past few years, in large part due to the results of the National Lung …

Management of ground-glass opacities in the lung cancer spectrum

Y Zhang, F Fu, H Chen - The Annals of thoracic surgery, 2020 - Elsevier
Background Along with the popularity of low-dose computed tomography lung cancer
screening, an increasing number of lung ground-glass opacity (GGO) lesions are detected …

Spectrum of lung adenocarcinoma

BD Hutchinson, GS Shroff, MT Truong, JP Ko - Seminars in Ultrasound, CT …, 2019 - Elsevier
Lung cancer remains the most common cause of cancer death in the United States of
America and worldwide despite continued advances in lung cancer screening as well as …

Screening for lung cancer: CHEST guideline and expert panel report

PJ Mazzone, GA Silvestri, LH Souter, TJ Caverly… - Chest, 2021 - Elsevier
Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States, in large part because of the results of the National Lung Screening Trial …

Contemporary issues in the implementation of lung cancer screening

S Lam, M Tammemagi - European Respiratory Review, 2021 - Eur Respiratory Soc
Lung cancer screening with low-dose computed tomography can reduce death from lung
cancer by 20–24% in high-risk smokers. National lung cancer screening programmes have …

Toward an expert level of lung cancer detection and classification using a deep convolutional neural network

C Zhang, X Sun, K Dang, K Li, X Guo, J Chang… - The …, 2019 - academic.oup.com
Background Computed tomography (CT) is essential for pulmonary nodule detection in
diagnosing lung cancer. As deep learning algorithms have recently been regarded as a …

Higher accuracy of [68 Ga]Ga-DOTA-FAPI-04 PET/CT comparing with 2-[18F]FDG PET/CT in clinical staging of NSCLC

X Zhou, S Wang, X Xu, X Meng, H Zhang… - European journal of …, 2022 - Springer
Purpose This study aimed to explore the clinical staging performance of [68 Ga] Ga-DOTA-
FAPI-04 PET/CT compared with that of 2-[18F] FDG PET/CT in non-small cell lung cancer …

Multiomics analysis reveals distinct immunogenomic features of lung cancer with ground-glass opacity

K Chen, J Bai, A Reuben, H Zhao, G Kang… - American journal of …, 2021 - atsjournals.org
Rationale: Ground-glass opacity (GGO)-associated lung cancers are common and
radiologically distinct clinical entities known to have an indolent clinical course and superior …